Does MOGAMULIZUMAB Cause Dermatitis exfoliative generalised? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Dermatitis exfoliative generalised have been filed in association with MOGAMULIZUMAB (POTELIGEO). This represents 1.6% of all adverse event reports for MOGAMULIZUMAB.
7
Reports of Dermatitis exfoliative generalised with MOGAMULIZUMAB
1.6%
of all MOGAMULIZUMAB reports
2
Deaths
5
Hospitalizations
How Dangerous Is Dermatitis exfoliative generalised From MOGAMULIZUMAB?
Of the 7 reports, 2 (28.6%) resulted in death, 5 (71.4%) required hospitalization.
Is Dermatitis exfoliative generalised Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOGAMULIZUMAB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does MOGAMULIZUMAB Cause?
Rash (59)
Disease progression (46)
Infusion related reaction (42)
Pyrexia (35)
Febrile neutropenia (29)
Erythema (28)
Pruritus (26)
Drug ineffective (24)
Constipation (22)
Death (21)
What Other Drugs Cause Dermatitis exfoliative generalised?
ALLOPURINOL (192)
DUPILUMAB (162)
METHOTREXATE (151)
SULFAMETHOXAZOLE\TRIMETHOPRIM (140)
AMOXICILLIN (122)
ADALIMUMAB (113)
PANTOPRAZOLE (105)
SECUKINUMAB (96)
VANCOMYCIN (92)
AMLODIPINE (91)
Which MOGAMULIZUMAB Alternatives Have Lower Dermatitis exfoliative generalised Risk?
MOGAMULIZUMAB vs MOGAMULIZUMAB-KPKC
MOGAMULIZUMAB vs MOLNUPIRAVIR
MOGAMULIZUMAB vs MOLSIDOMINE
MOGAMULIZUMAB vs MOMELOTINIB
MOGAMULIZUMAB vs MOMETASONE